C09999453 / invoice 10000

Species:CANINE
Breed:British Bulldog
Age (years):6
Diagnosis or signs:Medication
Consult notes
Plan for Sully:β€’	Continue strict diet trialβ€’	Continue sulfasalazine 1 tablet SID β€’	Start cyclosporine 5 mg/kg SID- prescription for owner to source from chemist - will taper β€’	Resume antibiotic course and add in amoxyclav alongside metronidazole  for 3 weeks  given previous culture** consider budesonideCyclosporineDuration:4–6 weeks minimumGoal during this phase:resolve clinical signsstabilise rectal inflammationstop recurrent anal sac infectionMany clinicians will not taper before 6 weeks, even if the dog looks better earlier.2. First taper (reduce frequency)Once stable for 2–4 weeks with no relapse:Reduce to 5 mg/kg every 48 hours for 4-6 weeks Monitor for recurrence of:rectal bleedingmucusanal gland dischargescooting or discomfortIf relapse occurs ? return to daily dosing.3. Second taperIf still stable after the EOD phase reduce to 5 mg/kg every 72 hoursContinue for 4–8 weeksSome dogs remain stable here long term.4. Long-term maintenance optionsDepending on the dog’s response, maintenance may be every 72 hours vs twice weekly or occasionally discontinuedMany chronic colitis dogs remain stable on low-frequency cyclosporine.5. Practical example protocolA common timeline:Weeks 0–6? 5 mg/kg SIDWeeks 6–12? 5 mg/kg EODWeeks 12–20? 5 mg/kg every 72 hrThen reassess whether ongoing therapy is needed.6. Drugs often continued alongside cyclosporineSulfasalazine during inductionstrict diet trial (e.g. Hill's Prescription Diet z/d)Sulfasalazine is sometimes tapered after cyclosporine is stabilised.7. Monitoring while on cyclosporineMost clinicians check:Baseline then periodic:CBCbiochemistryurinalysisWatch for:GI upset (most common early effect)gingival hyperplasiapapillomasopportunistic infectionsClinical improvement usually appears within 2–4 weeksFull mucosal stabilisation may take 6–8 weeks

Animal clinical history (3 most recent)

2026-03-05T00:00:00Z 8:19?pm
Plan for Sully:β€’	Continue strict diet trialβ€’	Continue sulfasalazine 1 tablet SID β€’	Start cyclosporine 5 mg/kg SID- prescription for owner to source from chemist - will taper β€’	Resume antibiotic course and add in amoxyclav alongside metronidazole  for 3 weeks  given previous culture** consider budesonideCyclosporineDuration:4–6 weeks minimumGoal during this phase:resolve clinical signsstabilise rectal inflammationstop recurrent anal sac infectionMany clinicians will not taper before 6 weeks, even if the dog looks better earlier.2. First taper (reduce frequency)Once stable for 2–4 weeks with no relapse:Reduce to 5 mg/kg every 48 hours for 4-6 weeks Monitor for recurrence of:rectal bleedingmucusanal gland dischargescooting or discomfortIf relapse occurs ? return to daily dosing.3. Second taperIf still stable after the EOD phase reduce to 5 mg/kg every 72 hoursContinue for 4–8 weeksSome dogs remain stable here long term.4. Long-term maintenance optionsDepending on the dog’s response, maintenance may be every 72 hours vs twice weekly or occasionally discontinuedMany chronic colitis dogs remain stable on low-frequency cyclosporine.5. Practical example protocolA common timeline:Weeks 0–6? 5 mg/kg SIDWeeks 6–12? 5 mg/kg EODWeeks 12–20? 5 mg/kg every 72 hrThen reassess whether ongoing therapy is needed.6. Drugs often continued alongside cyclosporineSulfasalazine during inductionstrict diet trial (e.g. Hill's Prescription Diet z/d)Sulfasalazine is sometimes tapered after cyclosporine is stabilised.7. Monitoring while on cyclosporineMost clinicians check:Baseline then periodic:CBCbiochemistryurinalysisWatch for:GI upset (most common early effect)gingival hyperplasiapapillomasopportunistic infectionsClinical improvement usually appears within 2–4 weeksFull mucosal stabilisation may take 6–8 weeks    Vital Signs    

Previous claim history (21)

DateClaim #Diagnosis
2026-03-05C09992818Cruciate Disease - Left Leg
2026-03-05C09992818INFLAMMATORY BOWEL DISEASE (IBD)
2026-03-05C09992818Cruciate Disease - Right Leg
2026-02-12C09895378INFLAMMATORY BOWEL DISEASE (IBD)
2026-01-29C09826879INFLAMMATORY BOWEL DISEASE (IBD)
2026-01-29C09826879ANAL SAC DISORDER
2026-01-14C09753573HEARTWORM CONTROL
2026-01-14C09753573VACCINATIONS OR HEALTH CHECKS
2026-01-14C09753573FLEA/TICK/WORM CONTROL
2025-12-30C09692664ANAL SAC DISORDER
2025-12-27C09678386PROCTITIS
2025-12-12C09624372PRESCRIPTION DIETS
2025-12-12C09624372PROCTITIS
2020-10-08C3215235DERMATITIS
2020-08-26C3121812COUGHING - PRESENTING COMPLAINT
2020-07-14C3029393INSECT BITE/STING
2020-05-15C2903765HEARTWORM CONTROL
2020-05-15C2903765FLEA/TICK/WORM CONTROL
2020-05-15C2903765ANAL SAC DISORDER
2020-03-24C2801946CHERRY EYE
2020-03-24C2801946DESEXING

Line items(lines with upstream diagnosis are skipped by the model)

LinetstarcAmountDateUpstream diagnosis
10000tstarc_antibiotics_-_amoxicillin_and_clavulanic_acid309.302026-03-05β€”
20000tstarc_prescription_fee25.002026-03-05β€”
30000tstarc_antibiotics_-_metronidazole21.802026-03-05β€”

UPM+

  • DG02377INFLAMMATORY BOWEL DISEASE (IBD)DSTP_inflammatory_bowel_disease_(ibd)

Variant (sleepy_king)

INFLAMMATORY BOWEL DISEASE (IBD)
DSTP_inflammatory_bowel_disease_(ibd)
Conf: 0.720
Threshold: 0.59
Above: βœ“
Correct?